Events Partner Content Pharmaceutical Microbiology UK Pharmaceutical Microbiology 22nd & 23rd January 2018 Holiday Inn Kensington Forum, London, UK
News AZ claims another win for Imfinzi in frontline liver cancer AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
